Cas:84994-24-1 2-MERCAPTOBENZOTHIAZOLEYL(Z)-2-AMINOTHIAZOL-4-YL-2-METHOXYIMINO ACETATE(MAEM) manufacturer & supplier

We serve Chemical Name:2-MERCAPTOBENZOTHIAZOLEYL(Z)-2-AMINOTHIAZOL-4-YL-2-METHOXYIMINO ACETATE(MAEM) CAS:84994-24-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-MERCAPTOBENZOTHIAZOLEYL(Z)-2-AMINOTHIAZOL-4-YL-2-METHOXYIMINO ACETATE(MAEM)

Chemical Name:2-MERCAPTOBENZOTHIAZOLEYL(Z)-2-AMINOTHIAZOL-4-YL-2-METHOXYIMINO ACETATE(MAEM)
CAS.NO:84994-24-1
Synonyms:2-mercaptobenzothiazoly(Z)-(2-aminothiazole-4-yl)-2-methoxyimino acetate;BENZOTHIAZOL-2-YL-2-(2-AMINOTHIAZOLE-4-YL)-(Z)-2-METHOXYIMINO THIOACETATE;O-1,3-Benzothiazol-2-yl (2Z)-(2-amino-1,3-thiazol-4-yl)(methoxyimino)ethanethioate;2-methoxyimino-2-(2-aminothiazol-4-yl)acetic acid S-2-benzothiazole ester;2-Mercaptobenzothiazolyl (Z)-2-(2-Aminothiazole-4-Yl)-2-Methoxyimino Acetate;Benzothiazol-2-yl (Z)-2-methoxyimino-2-(2-aminothiazole-4-yl)thioacetate;MFCD00799968;4-Thiazoleethanethioic acid, 2-amino-α-(methoxyimino)-, O-2-benzothiazolyl ester, (αZ)-;(Z)-2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic acid 2-benzothiazolyl este;EINECS 279-540-6;(Benzothazol-2-yl)-2-(2-Aminothiazole-4-yl)-(Z)-2-MethoxyiminoThioacetate;2-MERCAPTOBENZOTHIAZOLEYL(Z)-2-AMINOTHIAZOL-4-YL-2-METHOXYIMINO ACETATE(MAEM)
Molecular Formula:C13H10N4O2S3
Molecular Weight:350.439
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:526.1±42.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.784
PSA:171.19000
Exact Mass:349.996582
LogP:3.65

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-mercaptobenzothiazoly(Z)-(2-aminothiazole-4-yl)-2-methoxyimino acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-MERCAPTOBENZOTHIAZOLEYL(Z)-2-AMINOTHIAZOL-4-YL-2-METHOXYIMINO ACETATE(MAEM) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(Z)-2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetic acid 2-benzothiazolyl este Use and application,2-methoxyimino-2-(2-aminothiazol-4-yl)acetic acid S-2-benzothiazole ester technical grade,usp/ep/jp grade.


Related News: This not only makes it easier to remove enzyme residues from the desired product, but also ensures valuable high turnover enzymes can be reused multiple times without compromising their activity. 5-methoxy-1,6-dimethyl-7,8-dihydroisoquinoline-7,8-dione manufacturers Moderna filed an application with the FDA for that same younger age group on June 10 but has yet to hear from the agency. States like Rhode Island have already signed off on allowing 12 to 17-year-olds to use the vaccine. 1-(4-(4-chlorophenyl)thiazol-2-yl)piperidine-4-carboxamide suppliers Events, Hatzalah of South Florida, and Ygrene and in partnership with the Shul of Bal Harbour we are able to continue this mission by providing first and last month rent as well as the security deposit for these families If this fund grows bigger, we will be able to continue to contribute funds directly for the rents.” Michael Capponi
“During this challenging time for the survivors, the uncertainty of not knowing where they will live exacerbates an already extremely painful and tragic situation. We are committed to the relocation efforts of all of the survivors through our partnership with Global Empowerment Mission.” Rabbi Zalman Lipskar, The Shul of Bal Harbour.
“We are devastated by the loss suffered by the victims, families of victims and the community at the hands of the Surfside tragedy. It is an honor to contribute to GEM’s Champlain Survivor Relocation Fund to provide safe and comfortable homes for survivors to help them get back on their feet, ” said Ygrene CEO, Jim Reinhart.
Baclofen is a muscle relaxant drug indicated for the treatment of muscle pain, spasms, and stiffness in people with multiple sclerosis, spinal cord injury, or disease.
This is Beximco Pharma’s ninth Abbreviated New Drug Application fully developed in-house and successfully approved for the US market since the Company’s oral solid dosage facility was approved by the US FDA in June 2015.
According to IQVIA audited market data, there are currently nine active players for Baclofen in the US market, which generated sales of more than $110 million in 2020.
Mr. Nazmul Hassan MP, Managing Director of Beximco Pharmaceuticals, said: We are pleased to have received FDA approval of Baclofen, a commonly prescribed medicine in the US, as we continue to leverage our core strengths in R&D and manufacturing to develop and deliver important generic products to patients. (E)-4-(4-Chloro-phenyl)-4-phenyl-but-3-en-2-one vendor & factory.